C07K 16/1235
Salmonella
Official title: Salmonella (G)
C07K16/1235 (Salmonella) appears on 49 US grants and 66 published applications in this corpus.
Search patents in C07K- Granted patents
- 49
- Published applications
- 66
- Assignees
- 52
- Inventors
- 128
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 3 | 0 |
| 1998 | 2 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 2 |
| 2006 | 0 | 1 |
| 2007 | 2 | 5 |
| 2008 | 0 | 2 |
| 2009 | 0 | 2 |
| 2010 | 0 | 1 |
| 2011 | 0 | 3 |
| 2012 | 2 | 1 |
| 2013 | 1 | 2 |
| 2014 | 3 | 5 |
| 2015 | 2 | 1 |
| 2016 | 1 | 5 |
| 2017 | 2 | 5 |
| 2018 | 4 | 5 |
| 2019 | 4 | 2 |
| 2020 | 2 | 4 |
| 2021 | 4 | 6 |
| 2022 | 2 | 4 |
| 2023 | 0 | 2 |
| 2024 | 4 | 4 |
| 2025 | 3 | 3 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Engineered binding proteins for recognition of bacteria11 Aug 2026US 12,704,514 B2Massachusetts Institute of Technology
- Apparatus and method for detecting microbial contamination4 Nov 2025US 12,461,100 B2S D Systems, Inc.
- Eradication of bacterial biofilm using anti-amyloid monoclonal antibodies21 Jan 2025US 12,202,887 B2Lankenau Institute of Medical Research
- Composition and methods for preventing and treating African swine fever in wild and domestic swine14 Jan 2025US 12,194,096 B2Stevens Law Group
- Compositions and methods for inhibiting pathogen infection15 Oct 2024US 12,115,219 B2The University of North Carolina at Chapel Hill
- IgY Antibody Compositions and Methods for Treating Avian Species25 Sep 2025US 2025/0295770 A1Mammal Labs Inc.
- Composition and Methods for Preventing and Treating African Swine Fever in Wild and Domestic Swine10 Jul 2025US 2025/0222101 A1Mammal Labs Inc.
- Compositions and methods for inhibiting pathogen infection13 Mar 2025US 2025/0082751 A1The University of North Carolina at Chapel Hill
- Chimeric secretory component polypeptides and uses thereof26 Dec 2024US 2024/0425570 A1The Board of Trustees of the University of Illinois
- Optimized crosslinkers for trapping a target on a substrate12 Dec 2024US 2024/0409622 A1The University of North Carolina at Chapel Hill
Most cited
By later US patents
- Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells52US 8,691,963 B2EnGeneIC Molecular Delivery Pty Ltd · 2014
- Bacterially derived intact minicells that encompass plasmid free functional nucleic acid for in vivo delivery to mammalian cells48US 8,735,566 B2EnGeneIC Molecular Delivery Pty Ltd · 2014
- Lipid A-preparation41US 4,029,762 AMax-Planck-Gesellschaft zur Forderung der Wissenschaften e.V. · 1977
- Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells25US 8,591,862 B2EnGeneIC Molecular Delivery Pty Ltd · 2013
- Compositions and methods for inhibiting pathogen infection11US 10,100,102 B2The Johns Hopkins University · 2018